10X Genomics股价创52周新高,达20.36美元
10X Genomics stock hits 52-week high at 20.36 USD By Investing.com - Investing.com Australia
生物技术与制药领域的最新动态
10X Genomics stock hits 52-week high at 20.36 USD By Investing.com - Investing.com Australia
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Orca adds $250M in financing to back launch of T cell therapy
In the clinic for Jan. 9, 2026
Other news to note for Jan. 9, 2026
Regulatory actions for Jan. 9, 2026
Money raised by biopharma
Biopharma money raised: Jan. 1-8, 2026
Illumina adds former NIH official as medical chief (ILMN:NASDAQ) - Seeking Alpha
Thermo Fisher Scientific to phase out Weaverville operations by end of 2026 - WLOS
Novartis to build fourth US radiotherapy factory in Florida
Insmed’s ‘ginormous’ lung drug sales; J&J’s US pricing deal
Venture firm a16z raises $700M; Ribo Life's $230M Hong Kong IPO
BioNTech, UPenn team up for $50M seed fund
Stress-induced sympathetic hyperactivation drives hair follicle necrosis to trigger autoimmunity
Thermodynamic principles link in vitro transcription factor affinities to single-molecule chromatin states in cells
Chutes & Ladders—Former Roche oncology head turns to Tubulis
Baby KJ scientist launches personalized CRISPR therapy startup
Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential